KOR  ENG
  • IR

  • AbClon’s strong foundations and innovative platforms will help drive the future of
    personalized medicine and safeguard the health and hopes of families.

IR자료

제목 [하나금융투자] 항체신약 플랫폼기술 보유회사
첨부파일 20180903_항체신약_플랫폼기술_보유회사선민정_애널리스트.pdf (810.9K) 날짜 2018-09-03 조회 353

1. 제목 : 항체신약 플랫폼기술 보유회사

2. 기관명 : 하나금융투자

3. 작성자 : 선민정 연구원

4. 분량 : 11page

5. 발간일 : 2018.09.03

Designed by CHAIRONE
© AbClon. All rights reserved.